Websphero-: prefix meaning "round or a sphere": spherocyte, spherolith, spherometer. WebMar 31, 2024 · Spero Therapeutics is developing SPR720 as a novel oral therapy candidate for the treatment of a rare, orphan pulmonary disease caused by non-tuberculous mycobacterial infections.
Did you know?
WebWebsite http://www.sperotherapeutics.com Industries Biotechnology Research Company size 11-50 employees Headquarters Cambridge, MA Type Public Company Founded 2013 Specialties Antibacterial... WebApr 6, 2024 · Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial …
WebSpero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial Web1 day ago · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments ...
WebOct 3, 2024 · CAMBRIDGE, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and... Web1 day ago · Spero Therapeutics is developing SPR720 as a novel oral therapy candidate for the treatment of a rare, orphan pulmonary disease caused by non-tuberculous …
WebProducts Sphero 1.0 and 2.0. The original Sphero was initially prototyped by its inventors, Ian Bernstein and Adam Wilson, with a 3D-printed shell and electronics taken from a smartphone. It was then demonstrated at CES in …
WebSep 5, 2024 · In June 2024, Spero Therapeutics had US$45m in cash, and was debt-free. Importantly, its cash burn was US$84m over the trailing twelve months. That means it had a cash runway of around 7 months... septal infarct life expectancyWebspero therapeutics, inc. STOCK OPTION AGREEMENT—INCORPORATED TERMS AND CONDITIONS AGREEMENT made as of the date of grant set forth in the Stock Option Grant Notice by and between Spero Therapeutics, Inc. (the “Company”), a Delaware corporation, and the individual whose name appears on the Stock Option Grant Notice (the “Participant”). septal infarct ekgWebSpero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for bacterial infections, … septal heart defectWebApr 10, 2024 · Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. septal hole in heartWebSpero Therapeutics Reschedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call to March 30, 2024 CAMBRIDGE, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high … septal hypertrophy echoWebMay 3, 2024 · Shares of Spero Therapeutics Inc. SPRO, plummeted 68.4% toward a record low in premarket trading Tuesday, after the Massachusetts-based biopharmaceutical company said it is cutting 75% of its ... thetabyteWebOct 3, 2024 · Founded in 2013, Spero Therapeutics is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. The company focuses on treatments with a novel therapeutic approach... septal infarction definition